Conference Track

Biomedical HIV Prevention Strategies

Source: CCO Official Conference Coverage of the 2009 IAS Conference on HIV Pathogenesis, Treatment and Prevention

Capsule Summaries

DREAM Cohort Study Results Indicate That Longer Duration of Prenatal HAART Leads to Greater Reductions in Risk of HIV-1 Mother-to-Child Transmission and Infant Death
Prenatal Use of HAART Associated With Improved Pregnancy and Maternal Outcomes Across All CD4+ Cell Count Strata
HIV Transmission in Serodiscordant Heterosexual Couples Dramatically Reduced When Index Partner on Antiretroviral Therapy
Mathematical Modeling Suggests Increased Condom Use, HAART Provision Has Greater Impact on HIV Incidence Among South African Men Than Circumcision
Acyclovir Treatment of HSV-2 in HSV-2/HIV-Coinfected Individuals Does Not Reduce HIV Transmission to HIV-Uninfected Partners
Acyclovir Treatment of HSV-2 in HIV-Coinfected Individuals Not Receiving Antiretroviral Therapy Reduces Risk of HIV Disease Progression
BAN Study: Maternal HAART, Infant Nevirapine Each Effective, Safe for Reducing Risk of HIV-1 Mother-to-Child Transmission During Breastfeeding
Pregnancy Common Among HIV-Discordant Couples in Kenya, Associated With Increased Risk of HIV-1 Transmission

Expert Analysis

Biomedical HIV Prevention Strategies

Faculty:

Sharon L. Hillier, PhD
Julio Montaner, MD, FRCPC, FCCP
Thomas Quinn, MD, MSc

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the results of studies investigating HAART as prevention in serodiscordant couples and mother-to-child transmission by breastfeeding
Discuss the use of acyclovir as a method of biomedical prevention in serodiscordant couples
Explain new data on circumcision as a modality of HIV prevention
Relate details of modeling exercises that describe the results of HIV testing and prevention interventions at the population level

Abstract

Click here to view abstract

CREDIT INFORMATION

Release Date: September 29, 2009

Expiration Date: September 28, 2010

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Registered Nurses: 0.5 Nursing contact hours

Pharmacists: 0.5 contact hours (0.05 CEUs)

Status: Please log in to view status

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.